Physician
Novant Health Medical Group, LLC
Novant Health Medical Group, LLC was paid $1.17M by Medicaid between Jan 2018 and Dec 2024, across 33 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoNOVANT HEALTH MEDICAL GROUP, LLC
CHARLOTTE, NC 28270
CHARLOTTE, NC 28270
33aNPI1013962307assigned 05/24/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.17M
24GClaims103,660
24DCodes billed33
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in North Carolina
Rank by total paid#122 of 960
Median peer was paid$135K
This provider vs. median8.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,877 | $176K | |
| 2019 | 3,508 | $179K | |
| 2020 | 2,253 | $120K | |
| 2021 | 11,525 | $214K | |
| 2022 | 26,748 | $254K | |
| 2023 | 25,455 | $142K | |
| 2024incomplete | 29,294 | $86K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 7,177 | 6,425 | $487K |
| 99199 | Unlisted special service, procedure or report | 26% | 85,187 | 82,818 | $302K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 5,481 | 4,879 | $297K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.5% | 779 | 719 | $29K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.2% | 778 | 730 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,272 | 1,157 | $9K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 61 | 55 | $6K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 150 | 145 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 37 | 36 | $4K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 28 | 26 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 54 | 54 | $3K |
| 90686 | <1% | 676 | 627 | $2K |
21 more codes
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 121 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 29 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 140 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 78 | $1K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 13 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 131 | $960.37 |
| 90674 | <1% | 88 | $540.55 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 31 | $528.45 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $338.64 |
| 81001 | <1% | 51 | $124.50 | |
| 92551 | <1% | 60 | $18.36 | |
| 99173 | <1% | 35 | $3.06 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 351 | $0.00 |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 0% | 264 | $0.00 |
| 90461 | 0% | 32 | $0.00 | |
| 99177 | 0% | 14 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 0% | 68 | $0.00 |
| G8732 | No documentation of pain assessment, reason not given | 0% | 264 | $0.00 |
| 1036F | 0% | 152 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 29 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALTON, LEEA (RCS MANAGER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.